✦ LIBER ✦

Immunotherapy of B-Cell Lymphoma with an Engineered Bispecific Antibody Targeting CD19 and CD5

✍ Scribed by Lüttgau, Sandra; Deppe, Dorothée; Meyer, Saskia; Fertig, Regina; Panjideh, Hossein; Lipp, Martin; Schmetzer, Oliver; Pezzutto, Antonio; Breitling, Frank; Moldenhauer, Gerhard

Book ID: 120423768
Publisher: MDPI AG
Year: 2013
Tongue: English
Weight: 588 KB
Volume: 2
Category: Article
ISSN: 2073-4468
DOI: 10.3390/antib2020338

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Costimulation with agonistic anti-CD28 a

Costimulation with agonistic anti-CD28 antibodies prevents T cell apoptosis and is required for efficient immunotherapy with CD3x19 bispecific antibodies in B cell lymphoma

✍ P.T. Daniel; A. Kroidl; A. Pezzutto; G. Moldenhauer; B. Dörken 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Cytokine-induced killer cells targeted b

Cytokine-induced killer cells targeted by the novel bispecific antibody CD19xCD5 (HD37xT5.16) efficiently lyse B-lymphoma cells

✍ Freddy Tita-Nwa; Gerhard Moldenhauer; Markus Herbst; Christian Kleist; Anthony D 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 360 KB

CD8 T cell activation after intravenous

CD8 T cell activation after intravenous administration of CD3×CD19 bispecific antibody in patients with non-Hodgkin lymphoma

✍ Gijsbert C. de Gast; Inez-Anne Haagen; Anja A. van Houten; Sigrid C. Klein; Ashl 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 710 KB

Locoregional treatment of low-grade B-ce

Locoregional treatment of low-grade B-cell lymphoma with CD3×CD19 bispecific antibodies and CD28 costimulation: I. Clinical phase I evaluation

✍ Oliver Manzke; Hans Tesch; Peter Borchmann; Jürgen Wolf; Klaus Lackner; Axel Gos 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 240 KB

We describe the first clinical application of T-cell-recruiting bispecific antibodies directly into the tumor without the need to preactivate the effector cells. In a Phase I clinical trial, 10 patients with low-grade B-cell lymphoma were treated by a single locoregional injection of CD3؋CD19 bispec

Locoregional treatment of low-grade B-ce

Locoregional treatment of low-grade B-cell lymphoma with CD3×CD19 bispecific antibodies and CD28 costimulation: II. Assessment of cellular immune responses

✍ Oliver Manzke; Hans Tesch; Johann Lorenzen; Volker Diehl; Heribert Bohlen 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 193 KB

Immunotherapy of relapsed B-cell lymphom

Immunotherapy of relapsed B-cell lymphoma with an anti-CD20 antibody (IDEC-C2B8)

✍ A.J. Grillo-López 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 271 KB